Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Qaseem: Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical.... (0.15 sec) 

Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical …


A Qaseem, V Snow, P Shekelle, K Sherif, TJ … - Annals of Internal Medicine, 2007 - Am Coll Physicians
Recommendation 1: In patients with respiratory symptoms, particularly dyspnea,
spirometry should be performed to diagnose airflow obstruction. Spirometry
should not be used to screen for airflow obstruction in asymptomatic ...
Cited by 44 - Related articles - BL Direct - All 18 versions

Screening for chronic obstructive pulmonary disease using spirometry: summary of the …

- annals.org [PDF] 
K Lin, B Watkins, T Johnson, JA Rodriguez, … - Annals of Internal Medicine, 2008 - Am Coll Physicians
Background: Chronic obstructive pulmonary disease (COPD) is the fourth leading
cause of death in the United States. Fewer than half of the estimated 24 million
Americans with airflow obstruction have received a COPD diagnosis, and ...
Cited by 20 - Related articles - BL Direct - All 10 versions

Management of stable chronic obstructive pulmonary disease: a systematic review for a …


TJ Wilt, D Niewoehner, R MacDonald, RL … - Annals of Internal Medicine, 2007 - Am Coll Physicians
Background: Chronic obstructive pulmonary disease (COPD) is a common and
disabling condition in adults. Information about therapeutic effectiveness and
adverse effects of common treatment options and how clinical and ...
Cited by 57 - Related articles - BL Direct - All 12 versions

[PDF] Canadian Thoracic Society recommendations for management of chronic obstructive …


EO Denis, MD Shawn Aaron, MD Jean Bourbeau … - Can Respir J, 2007 - progettolibra.it
*Member of the editorial committee 1Queen's University, Kingston; 2University of
Ottawa, Ottawa, Ontario; 3McGill University, Montreal, Quebec; 4Dalhousie
University, Halifax, Nova Scotia; 5University of Saskatchewan, Saskatoon, ...
Cited by 69 - Related articles - All 18 versions

Chronic obstructive pulmonary disease in the older patient

- terapiaintensivacali.com [PDF] 
SA Nazir, MM Al-Hamed, ML Erbland - Clinics in Chest Medicine, 2007 - Elsevier
The burden of COPD has been increasing for the last two decades, and it is
projected to continue to increase for the next few [3] and [4]. In the year
2000, COPD became the fourth leading cause of death and is projected to be ...
Cited by 6 - Related articles - All 38 versions

Treating COPD-The TORCH trial, P values, and the dodo

- lumc.nl [PDF] 
KF Rabe - New England Journal of Medicine, 2007 - nejm.org
In the United States, the overall, age-standardized death rate decreased from
1242 deaths per 100,000 population in 1970 to 845 deaths per 100,000 in 2002.
This good news must be viewed against the doubling during the same interval ...
Cited by 39 - Related articles - BL Direct - All 11 versions

Spirometry Utilization for COPD*


MLK Han, MG Kim, R Mardon, P Renner, S … - Chest, 2007 - chestjournal.chestpubs.org
Methods: The National Committee for Quality Assurance recruited five health
plans to determine the proportion of patients ≥ 40 years old with a new
diagnosis of COPD who had received spirometry during the interval starting ...
Cited by 26 - Related articles - BL Direct - All 5 versions

Effect of formoterol/budesonide combination on arterial blood gases in patients with acute …

- goldcopd.it [PDF] 
M Cazzola, P Noschese, F De Michele, GD' … - Respiratory medicine, 2006 - Elsevier
We first compared the acute effects on gas exchange of two doses of formoterol
Turbuhaler (9 and 18 μg) in 10 patients with acute exacerbation of COPD.
Afterwards, we compared the acute effects of formoterol Turbuhaler 9 μg ...
Cited by 10 - Related articles - All 15 versions

Methodological issues in therapeutic trials of COPD

- ersjournals.com
S Suissa, P Ernst, KL Vandemheen, SD Aaron - European Respiratory Journal, 2008 - Eur Respiratory Soc
First, among previous ICS users in the Canadian Optimal Therapy of COPD Trial,
the hazard ratio of the first exacerbation with ICS relative to bronchodilators
was 0.71 (95% confidence interval (CI) 0.53–0.96), while among those not ...
Cited by 27 - Related articles - BL Direct - All 8 versions

[PDF] Use of spirometry for case finding, diagnosis, and management of chronic obstructive …


TJ Wilt, D Niewoehner, C Kim, RL Kane, A … - Evid Rep Technol Assess (Summ), 2005 - ahrq.gov
Prepared for: Agency for Healthcare Research and Quality US Department of Health
and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov ...
Prepared by: Minnesota Evidence-based Practice Center, Minneapolis, Minnesota
Cited by 44 - Related articles - View as HTML - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google